Flattery will get you nowhere!
Just being honest. Most discussions here are carried/corrected by your knowledge of the biotech markets.....but yes enough flattery for today.
But, seriously, I think IDIX did have a good CC.
Dew, do you have a link for the CC. I would like to listen to it tonight.
In this market, it was especially important that the CFO stated in plain language that IDIX is well capitalized and does not have a liquidity problem.
That's great to here, however, that IMHO, does not exclude the opportunity for a financing assuming two things:
1) There is a BD left out there that can execute a PIPE and/or any other type of financing(hopefully not a debt deal)
2)They liscense a portion more of the company to BP for more operating capital, when the timing is right.
oxy
Market Data 
Markets 
AI
